Organon and Eli Lilly expand global reach of migraine treatment Emgality
Organon and Eli Lilly and Company have expanded their commercialization agreement for Emgality, a leading migraine treatment, into 11 additional markets, reinforcing their commitment to addressing one of the most prevalent neurological disorders worldwide. Organon and Eli Lilly Expand Emgality Agreement Organon, a global healthcare company with a focus on women’s health, and Eli Lilly […]